NTRA (US)


April 23, 2026

RAPID Device Coverage: Rebrand or Brand New?

By John Leppard

The joint CMS / FDA press release this morning outlining the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway for breakthrough medical devices strikes us more as a rebranding of the existing transitional…

Read More >>

July 23, 2025

Guardant Health (GH) Reveal Rate Expectations

By John Leppard

We view CMS’s clinical laboratory advisory panel today as an incremental positive for Guardant Health (GH), despite what appears to be a lack of endorsement for the company’s request that payments for Reveal (0569U: $1,644)…

Read More >>